Diabetes Occurred After Zyprexa Warnings Given, 2nd Circuit Affirms

Diabetes Occurred After Zyprexa Warnings Given, 2nd Circuit Affirms

NEW YORK - A Zyprexa plaintiff developed diabetes after manufacturer defendant Eli Lilly and Co. warned doctors about that risk, a panel of the Second Circuit U.S. Court of Appeals held Sept. 26, affirming summary judgment for the defendant (Christopher Shepherd v. Eli Lilly and Company,  No. 11-3056, 2nd Cir.).

Find full version on lexis Advance®
Access this news story on lexis.com®